
Taeyoon Kim
Examiner (ID: 4325, Phone: (571)272-9041 , Office: P/1651 )
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1651, 1631, 1632 |
| Total Applications | 1176 |
| Issued Applications | 467 |
| Pending Applications | 170 |
| Abandoned Applications | 584 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16361326
[patent_doc_number] => 20200318077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => METHOD TO REPRODUCE CIRCADIAN RHYTHMS ON A MICROFLUIDIC CHIP
[patent_app_type] => utility
[patent_app_number] => 16/905987
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30132
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16905987
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/905987 | Method to reproduce circadian rhythms on a microfluidic chip | Jun 18, 2020 | Issued |
Array
(
[id] => 16541271
[patent_doc_number] => 20200407684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => METHOD FOR THE SELECTIVE DIFFERENTIATION INTO M1 MACROPHAGES
[patent_app_type] => utility
[patent_app_number] => 16/898072
[patent_app_country] => US
[patent_app_date] => 2020-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3603
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16898072
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/898072 | Method of selectively differentiating undifferentiated macrophage into M1 macrophage | Jun 9, 2020 | Issued |
Array
(
[id] => 18020985
[patent_doc_number] => 20220372484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => FPR2 RECEPTOR AGONIST APTAMERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/618104
[patent_app_country] => US
[patent_app_date] => 2020-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17618104
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/618104 | FPR2 RECEPTOR AGONIST APTAMERS AND USES THEREOF | Jun 8, 2020 | Pending |
Array
(
[id] => 17759960
[patent_doc_number] => 20220233572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => TREATMENT OF TLR-4 MEDIATED DISEASES AND CONDITIONS WITH APTAMERS TARGETING TLR-4
[patent_app_type] => utility
[patent_app_number] => 17/611497
[patent_app_country] => US
[patent_app_date] => 2020-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611497
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/611497 | TREATMENT OF TLR-4 MEDIATED DISEASES AND CONDITIONS WITH APTAMERS TARGETING TLR-4 | May 15, 2020 | Pending |
Array
(
[id] => 16970680
[patent_doc_number] => 11066643
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Natural killer cells with enhanced viability, proliferation and cytotoxicity following cryopreservation
[patent_app_type] => utility
[patent_app_number] => 15/931393
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 10
[patent_no_of_words] => 3533
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931393
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/931393 | Natural killer cells with enhanced viability, proliferation and cytotoxicity following cryopreservation | May 12, 2020 | Issued |
Array
(
[id] => 16362410
[patent_doc_number] => 20200319161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => METHOD OF IDENTIFYING ADIPOSE STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 16/869501
[patent_app_country] => US
[patent_app_date] => 2020-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16869501
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/869501 | METHOD OF IDENTIFYING ADIPOSE STEM CELLS | May 6, 2020 | Abandoned |
Array
(
[id] => 16437357
[patent_doc_number] => 20200354683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => DERIVATION OF HEPATIC STEM CELLS AND MATURE LIVER CELL TYPES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/865820
[patent_app_country] => US
[patent_app_date] => 2020-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16865820
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/865820 | Derivation of hepatic stem cells and mature liver cell types and uses thereof | May 3, 2020 | Issued |
Array
(
[id] => 17865352
[patent_doc_number] => 20220288087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => PIM1 INHIBITORS FOR USE IN TREATMENT OF VIRAL INFECTION AND PHARMACEUTICAL COMPOSITIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/594707
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7874
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594707
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594707 | PIM1 inhibitors for use in treatment of viral infection and pharmaceutical compositions thereof | Apr 29, 2020 | Issued |
Array
(
[id] => 16484258
[patent_doc_number] => 20200377859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => UMBILICAL CORD MESENCHYMAL STEM CELLS (MSCS) AND CULTURE METHOD AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/862510
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16862510
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/862510 | Umbilical cord mesenchymal stem cells (MSCs) and culture method and application thereof | Apr 28, 2020 | Issued |
Array
(
[id] => 17685915
[patent_doc_number] => 20220193207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/606410
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17606410
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/606410 | COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE | Apr 28, 2020 | Abandoned |
Array
(
[id] => 17685915
[patent_doc_number] => 20220193207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/606410
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17606410
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/606410 | COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE | Apr 28, 2020 | Abandoned |
Array
(
[id] => 20356291
[patent_doc_number] => 12472270
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Methods and compositions for reprogramming Muller Glia
[patent_app_type] => utility
[patent_app_number] => 17/594661
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5914
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594661
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594661 | Methods and compositions for reprogramming Muller Glia | Apr 28, 2020 | Issued |
Array
(
[id] => 18034525
[patent_doc_number] => 20220378740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => COMPOSITIONS AND METHODS OF MAKING EXPANDED HEMATOPOIETIC STEM CELLS USING DERIVATIVES OF CARBAZOLE
[patent_app_type] => utility
[patent_app_number] => 17/605719
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17860
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -112
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605719
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605719 | COMPOSITIONS AND METHODS OF MAKING EXPANDED HEMATOPOIETIC STEM CELLS USING DERIVATIVES OF CARBAZOLE | Apr 28, 2020 | Abandoned |
Array
(
[id] => 17702865
[patent_doc_number] => 20220202871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => METHOD FOR THE TREATMENT OF PERIODONTAL DISEASE USING CHARACTERIZED MESENCHYMAL STEM CELL GROWTH FACTORS AND EXOSOMES
[patent_app_type] => utility
[patent_app_number] => 17/606514
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9167
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17606514
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/606514 | METHOD FOR THE TREATMENT OF PERIODONTAL DISEASE USING CHARACTERIZED MESENCHYMAL STEM CELL GROWTH FACTORS AND EXOSOMES | Apr 28, 2020 | Pending |
Array
(
[id] => 16541278
[patent_doc_number] => 20200407691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => Methods and Materials for Modulation of Cell Secretome Production and Composition
[patent_app_type] => utility
[patent_app_number] => 16/857932
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16857932
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/857932 | Methods and Materials for Modulation of Cell Secretome Production and Composition | Apr 23, 2020 | Abandoned |
Array
(
[id] => 17168484
[patent_doc_number] => 20210322154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => Method of Processing Collagen-based Tissue for Bioprosthetic Devices
[patent_app_type] => utility
[patent_app_number] => 16/849694
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4017
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16849694
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/849694 | Method of processing collagen-based tissue for bioprosthetic devices | Apr 14, 2020 | Issued |
Array
(
[id] => 17671061
[patent_doc_number] => 20220184228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => METHODS OF PROMOTING LONG-TERM SURVIVAL OF PATIENTS WITH ADVANCED CHEMOTHERAPY-RESISTANT MALIGNANCIES
[patent_app_type] => utility
[patent_app_number] => 17/603268
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17603268
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/603268 | METHODS OF PROMOTING LONG-TERM SURVIVAL OF PATIENTS WITH ADVANCED CHEMOTHERAPY-RESISTANT MALIGNANCIES | Apr 12, 2020 | Pending |
Array
(
[id] => 20453050
[patent_doc_number] => 12516100
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Methods for producing regulatory B cells and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/602922
[patent_app_country] => US
[patent_app_date] => 2020-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 10219
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602922
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/602922 | Methods for producing regulatory B cells and uses thereof | Apr 8, 2020 | Issued |
Array
(
[id] => 17657453
[patent_doc_number] => 20220177918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => METHODS FOR TREATING INHERITED EYE DEFECTS
[patent_app_type] => utility
[patent_app_number] => 17/602987
[patent_app_country] => US
[patent_app_date] => 2020-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602987
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/602987 | METHODS FOR TREATING INHERITED EYE DEFECTS | Apr 6, 2020 | Pending |
Array
(
[id] => 16221272
[patent_doc_number] => 20200246388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => Method For Enhancing Expression Of Insulin Like Growth Factor 1 Receptor In Mesenchymal Stem Cell, Method For Obtaining Mesenchymal Stem Cell, And Method For Treating Brain Tissue Damage
[patent_app_type] => utility
[patent_app_number] => 16/835771
[patent_app_country] => US
[patent_app_date] => 2020-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16835771
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/835771 | Method for enhancing expression of insulin like growth factor 1 receptor in mesenchymal stem cell, method for obtaining mesenchymal stem cell, and method for treating brain tissue damage | Mar 30, 2020 | Issued |